Beta-lactamase inhibitors
US10669290B2 · kind B2 · utility
6Cited by
24References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 2, 2019 |
| Grant date | Jun 2, 2020 |
| Priority date | — |
| Expiry date | Jan 2, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.